Accessibility Menu
ViviCells International logo

ViviCells International(OTC) VCII

Market Cap$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-100%
5 Year-100%
1 Year-99%
1 Month+0%
$0.00
+0.00%
+0.00Today
ViviCells International last closing stock price
MetricPriceDate
Last closeUSD 0.002026-06-30
ViviCells International stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-04-15
1 month+0%USD 0.002026-04-15
3 month+0%USD 0.002026-03-16
Year to date-99%USD 0.002025-10-27
1 year-99%USD 0.002025-06-18
3 year-99%USD 0.002023-06-30
5 year-99.98%USD 0.012021-06-07
Since inception-100%USD 11.902003-09-09

ViviCells International Financials at a Glance

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-10.73 (Low)

Price

$0.00

Volume

358

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

VCII News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ViviCells International

ViviCells International, Inc. specializes in the preservation of stem cells, providing innovative solutions in the renewable utilities sector. Established in 1995 and headquartered in Evanston, Illinois, the company has evolved significantly since adopting its current name in 2008.

Products and Services
  • Stem cell preservation services for medical and research purposes
  • Consultation and support for stem cell storage and usage
  • Educational resources on the benefits of stem cell technology
Growth Outlook
  • Increasing global demand for stem cell therapies and preservation
  • Expansion into new markets with growing healthcare needs
  • Potential partnerships with research institutions and healthcare providers
Financial Highlights
  • Market capitalization stands at approximately $11,388
  • Recent trading volume indicates active investor interest
  • Price-to-book ratio reflects significant undervaluation potential
ViviCells International, Inc. operates in a niche market with substantial growth potential, driven by the increasing recognition of stem cell therapies. The company's focus on preserving stem cells positions it well to capitalize on emerging healthcare trends. Despite current financial challenges, the market capitalization and trading volume suggest a level of investor interest that could lead to future opportunities. The low price-to-book ratio indicates that the company may be undervalued, presenting a potential entry point for investors looking to engage in the renewable utilities sector.
AI Generated • Aug 3, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Headquarters

Evanston, IL 60201, US

VCII Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-0.73%

Return on Capital

-0.66%

Return on Assets

-0.64%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

113.88M

Volume

358

Avg. Volume

5.683

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$5.19K

EBITDA

-$5.19K

Operating Cash Flow

-$1.21M

Capital Expenditure

-$49.02K

Free Cash Flow

-$1.26M

Cash & ST Invst.

$0.00

Total Debt

$72.00K

ViviCells International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FEWPFar East Wind Power Corp.
$0.00+0.00%
CMNRCommerce Energy Group, Inc.
$0.00+0.00%
ZHYLFZhaoheng Hydropower Ltd.
$0.00+0.00%
QSPWQuantum Solar Power Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$138.74+0.04%
ACHRArcher Aviation
$6.26+0.12%
NVDANvidia
$217.55-0.03%
INTCIntel
$97.52-0.04%

Questions About VCII

What is the current price of ViviCells International?

ViviCells International is trading at $0.00 per share.

What is the 52-week range for ViviCells International?

Over the past 52 weeks, ViviCells International has traded between $0.00 and $0.00.

How much debt does ViviCells International have?

ViviCells International total debt is unavailable.

How much cash does ViviCells International have on hand?

ViviCells International does not have cash on hand data available.

What is ViviCells International’s dividend yield?

ViviCells International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services